Skip to main content

Advertisement

Table 2 Demographic and clinical characteristics*

From: Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial

  Intervention group (I) N = 43 Control group (C) N = 42
Demographic characteristics Median (range)  
Age 61.0 (30 – 81) 60.5 (35–79)
Gender n (%)  
Male 36 (83.7) 35 (83.3)
Female 7 (16.3) 7 (16.7)
ECOG PS ≤1 34 (79.1) 38 (90.5)
Social status   
Married/living together 31 (72.1) 34 (81.0)
Profession   
Labourer 18 (41.9) 17 (40.5)
Employee 20 (46.5) 19 (45.2)
Self-employed 5 (11.6) 5 (11.9)
  Median (Q1, Q3)  
Alcohol consumption (U/day) 4.0 (1.0, 8.0) 3.0 (1.0, 6.3)
Tobacco consumption (PY) 25.5 (8.6, 40.3) 35.0 (17.8, 50.0)
Clinical characteristics n (%)  
Tumour location   
Oral cavity 11 (25.6) 7 (16.7)
Oropharynx 17 (39.5) 17 (40.5)
Hypopharynx 7 (16.3) 4 (9.5)
Nasopharynx 2 (4.7) 2 (4.8)
Supraglottis 2 (4.7) 7 (16.7)
Glottis 2 (4.7) 2 (4.8)
Occult primary 2 (4.7) 3 (7.1)
Tumour stage   
Early stage (I-II) 6 (14.0) 8 (19.0)
Late stage (III-IVb) 37 (86.0) 34 (81.0)
Therapy initiation   
Neoadjuvant chemotherapy + radiochemotherapy 2 (4.7) 4 (9.5)
Primary radiotherapy   
 Alone 7 (16.3) 8 (19.0)
 With chemotherapy 22 (51.2) 18 (42.9)
 With biotherapy 0 (0.0) 2 (4.8)
Adjuvant radiotherapy   
 Alone 5 (11.6) 3 (7.1)
 With chemotherapy 7 (16.3) 7 (16.7)
 With biotherapy 0 (0.0) 0 (0.0)
Nutritional characteristics Median (Q1, Q3)  
6-months weight loss (%) 2.5 (6.8, −1.5) 2.2 (5.4, 2.4)
BMI (kg/m2) 22.80 (20.50, 28.70) 24.25 (21.8, 27.2)
PG-SGA score 10.0 (5.0, 15.0) 8.5 (6.8, 13.0)
Caloric intake (kcal/day) 1784 (1449, 2284) 1759 (1531, 2198)
  1. *Both groups did not significantly differ in demographic, nor clinical, nor nutritional characteristics at P < 0.05.